Sarepta Therapeutics Inc (SRPT)
133.68
+3.10
(+2.37%)
USD |
NASDAQ |
May 03, 16:00
133.68
0.00 (0.00%)
After-Hours: 20:00
Sarepta Therapeutics Normalized PE Ratio
Normalized PE Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Normalized PE Ratio Data
| Date | Value |
|---|---|
| May 02, 2024 | -- |
| May 01, 2024 | -- |
| April 30, 2024 | -- |
| April 29, 2024 | -- |
| April 26, 2024 | -- |
| April 25, 2024 | -- |
| April 24, 2024 | -- |
| April 23, 2024 | -- |
| April 22, 2024 | -- |
| April 19, 2024 | -- |
| April 18, 2024 | -- |
| April 17, 2024 | -- |
| Date | Value |
|---|---|
| April 16, 2024 | -- |
| April 15, 2024 | -- |
| April 12, 2024 | -- |
| April 11, 2024 | -- |
| April 10, 2024 | -- |
| April 09, 2024 | -- |
| April 08, 2024 | -- |
| April 05, 2024 | -- |
| April 04, 2024 | -- |
| April 03, 2024 | -- |
| April 02, 2024 | -- |
| April 01, 2024 | -- |
Price to Earnings Ratio (PE Ratio) Definition
The Price to Earnings Ratio (PE Ratio) is calculated by taking the stock price / EPS Diluted (TTM). This metric is considered a valuation metric that confirms whether the earnings of a company justifies the stock price. There isn't necesarily an optimum PE ratio, since different industries will have different ranges of PE Ratios. Because of this, PE Ratio is great to evaluate from a relative standpoint with other similar companies.